2001 Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

Volume 5, 2001 CD
Six back issues from 2001 on one convenient CD.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 5 No. 1	January/February 2001	Compounding for Pediatric Patients
Vol. 5 No. 2	March/April 2001	Compounding for Animals
Vol. 5 No. 3	May/June 2001	The Business of Compounding
Vol. 5 No. 4	July/August 2001	Sterile Product Compounding
Vol. 5 No. 5	September/October 2001	Bioidentical Hormone Replacement Therapy
Vol. 5 No. 6	November/December 2001	High-Tech Compounding

Volume 5, 2001 CD ARTICLES

Title (Click for Details)	Vol/Issue	Page

Volume 5, 2001 CD ARTICLES
Pediatric Compounding: Coloring Outside the Lines	Vol. 5 No. 1	6
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients	Vol. 5 No. 1	9
Flavoring: Compounding a Treat	Vol. 5 No. 1	13
Autism in Children	Vol. 5 No. 1	18
Methylphenidate in the Treatment of Attention Deficit Disorders	Vol. 5 No. 1	21
A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature	Vol. 5 No. 1	23
Book Reviews: Stability and Formulation References	Vol. 5 No. 1	25
Glycopyrrolate 1% Cream	Vol. 5 No. 1	28
Topical Therapy for Localized Hyperhidrosis	Vol. 5 No. 1	28
Methenamine 5% Lotion	Vol. 5 No. 1	29
Compounding in History: Pediatric Considerations	Vol. 5 No. 1	30
Profile of a Practice	Vol. 5 No. 1	32
The Basics of Compounding Powders and Granules	Vol. 5 No. 1	36
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations	Vol. 5 No. 1	38
Menthol Dusting Powder-Example of Powder Formulations	Vol. 5 No. 1	38
Cholestyramine 6.5% Ointment	Vol. 5 No. 1	42
Ivermectin 0.8% Creme Rinse	Vol. 5 No. 1	43
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel	Vol. 5 No. 1	44
Lorazepam 1-mg Chewable Gummy Gels	Vol. 5 No. 1	45
Metronidazole Benzoate 400-mg/5-mL Oral Suspension	Vol. 5 No. 1	46
Milk of Magnesia Concentrate, Unflavored	Vol. 5 No. 1	47
Natural Head Lice Repellant Spray	Vol. 5 No. 1	48
Niacinamide 4% Acne Gel	Vol. 5 No. 1	49
Poison Ivy Gel with 1% Hydrocortisone	Vol. 5 No. 1	50
Promethazine HCl 50-mg/mL in PLO Gel	Vol. 5 No. 1	51
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2	Vol. 5 No. 1	52
Rhodococcus Equi Pneumonia in Foals	Vol. 5 No. 1	55
Sterile-Product Preparations: Mix or Buy?	Vol. 5 No. 1	59
Oral Liquid Vehicles, Featured Excipient:	Vol. 5 No. 1	65
Purchasing Chemicals for Pharmaceutical Compounding	Vol. 5 No. 1	67
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs	Vol. 5 No. 1	69
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 5 No. 1	73
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 5 No. 1	75
Calculations	Vol. 5 No. 1	78
The Use of Psychoactive Agents in Veterinary Medicine	Vol. 5 No. 2	86
Benzoate or Not to Benzoate: Cats Are the Question, To	Vol. 5 No. 2	89
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension	Vol. 5 No. 2	92
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1	Vol. 5 No. 2	95
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding	Vol. 5 No. 2	97
Drugs Banned for Use in Food Animals: An Explanation	Vol. 5 No. 2	101
A Simplified Guide to Veterinary Compounding	Vol. 5 No. 2	104
Equipment for Large-Volume Aseptic Veterinary Compounding	Vol. 5 No. 2	106
Compounded Injectables for Veterinary Use	Vol. 5 No. 2	107
Book Reviews: Veterinary Compounding	Vol. 5 No. 2	108
From Wagon-Era Paregoric to Computer-Era Herbals	Vol. 5 No. 2	112
Wish You Were Here: The Niagara Apothecary	Vol. 5 No. 2	116
Profile of a Practice: Custom Rx Compounding and Natural Pharmacy	Vol. 5 No. 2	118
The Basics of Compounding Emulsions, Part 1	Vol. 5 No. 2	120
Diazoxide 50-mg/mL Suspension, Veterinary	Vol. 5 No. 2	126
Dimethyl Sulfoxide 50% Cream, Veterinary	Vol. 5 No. 2	127
EDTA-TRIS Otic Solution V-2 (Veterinary)	Vol. 5 No. 2	128
Flea Bite Gel	Vol. 5 No. 2	129
Gentamicin, Polymyxin, Neomycin, and Hydrocortisone Otic Drops	Vol. 5 No. 2	130
Iodine 2% in Oil Injection	Vol. 5 No. 2	131
Methimazole 5-mg/0.1-mL in Pluronic Lecithin Organogel	Vol. 5 No. 2	132
Sucrose Octaacetate and Capsicum Spray for Pets	Vol. 5 No. 2	133
Veterinary Antiseptic Emollient	Vol. 5 No. 2	134
Veterinary Oral Pastes	Vol. 5 No. 2	135
Infertility Care and the Role of the Compounding Pharmacist	Vol. 5 No. 2	136
Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing	Vol. 5 No. 2	140
Ointment Vehicles, Featured Excipient:	Vol. 5 No. 2	145
Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding	Vol. 5 No. 2	147
Chemical Stability of Methylprednisolone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes	Vol. 5 No. 2	148
Stability of Cefepime Hydrochloride After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 5 No. 2	151
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate	Vol. 5 No. 2	153
Calculations	Vol. 5 No. 2	157
PostScription: Case Reports and Formulations, George Roentsch, RPh.	Vol. 5 No. 2	160
Piracetam 100-mg, Ergoloid Mesylates 6-mg, and Selegiline 2.5-mg/0.2-mL Gel ("Brain Gel")	Vol. 5 No. 2	160
Oxytetracycline 15-mg/0.1-mL TD Cream	Vol. 5 No. 2	160
Motivation and Management: How to Build Your Business into the Job You Love	Vol. 5 No. 3	166
A New Trend in Pharmacy Practice: Private Consultations	Vol. 5 No. 3	170
Formulations for Success in Compounding, Part 1	Vol. 5 No. 3	174
Developing a Business Plan for a Compounding Specialty Pharmacy	Vol. 5 No. 3	176
Pricing Strategies	Vol. 5 No. 3	180
The Pharmacist Manpower Shortage: How to Recruit and Retain Key Employees	Vol. 5 No. 3	182
Book Reviews: Business Topics for Compounding Pharmacists	Vol. 5 No. 3	185
Software for the Compounding Pharmacist: A Review	Vol. 5 No. 3	187
Capsule-Weighing and Trituration Calculations	Vol. 5 No. 3	192
Irrigation with Piperacillin for the Treatment of Bladder Infection: A Case Study	Vol. 5 No. 3	195
Compounding in History: Compounding Economics	Vol. 5 No. 3	196
Stoughton's Bitters	Vol. 5 No. 3	197
Tinctura Kino Composita	Vol. 5 No. 3	197
The Basics of Compounding Emulsions, Part 2	Vol. 5 No. 3	198
Dry Skin and Massage Lotion-Example	Vol. 5 No. 3	201
Amphotericin 5-mg/mL Nasal Inhalation	Vol. 5 No. 3	204
Anthralin 1% in Lipid Crystals Cream	Vol. 5 No. 3	205
Bifonazol 1% and Urea 40% in White Petrolatum	Vol. 5 No. 3	206
Hand Cream, Protective	Vol. 5 No. 3	207
Idoxuridine 15% in Dimethyl Sulfoxide (DMSO)	Vol. 5 No. 3	208
Mitomycin 0.02% Ophthalmic Solution	Vol. 5 No. 3	209
Phenytoin 100- to 400-mg Rectal Suppositories	Vol. 5 No. 3	210
Tacrolimus 0.3% Ointment	Vol. 5 No. 3	211
Tetracycline HCl 1% Ophthalmic Ointment	Vol. 5 No. 3	212
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution	Vol. 5 No. 3	213
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2	Vol. 5 No. 3	214
The American Veterinary Medical Association Compounding Position Statement	Vol. 5 No. 3	216
Natural Progesterone in Natural Hormone Replacement Therapy, The Role of	Vol. 5 No. 3	218
Pharmacy Cleanroom Project Management Considerations: An Experience-Based Perspective	Vol. 5 No. 3	221
Establishing and Maintaining a Compounding Pharmacy Reference Library	Vol. 5 No. 3	226
Official Water-Repelling Agents: The Official Silicones, Featured Excipient:	Vol. 5 No. 3	228
Calculations	Vol. 5 No. 3	229
Stability of Piperacillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 5 No. 3	230
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid	Vol. 5 No. 3	232
Preparation and Evaluation of Sustained Drug Release from Pluronic Polyol Rectal Suppositories	Vol. 5 No. 3	234
PostScription: Compounding Pharmacists	Vol. 5 No. 3	240
Quality Assurance for Sterile Products	Vol. 5 No. 4	246
Sterile Compounding with Barrier-Isolation Technology	Vol. 5 No. 4	254
Bacterial Endotoxins and Pyrogens	Vol. 5 No. 4	259
Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices"	Vol. 5 No. 4	265
Antineoplastic Agents	Vol. 5 No. 4	268
Compounding Issues and Accreditation Agencies	Vol. 5 No. 4	273
Book Reviews	Vol. 5 No. 4	275
Sterile Compounding: Excerpts from the Reviews of Current Published Literature	Vol. 5 No. 4	278
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole	Vol. 5 No. 4	282
Analytical Testing Facilities and Products	Vol. 5 No. 4	284
Formulations for Success, Part 2	Vol. 5 No. 4	287
Wish You Were Here: The Stabler-Leadbeater Apothecary Museum	Vol. 5 No. 4	290
Basics of Compounding: Suspensions	Vol. 5 No. 4	294
Suspension Structured Vehicle, USP	Vol. 5 No. 4	296
Sugar-Free Suspension Structured Vehicle, USP	Vol. 5 No. 4	296
Spironolactone Oral Suspension 2-mg/mL	Vol. 5 No. 4	297
Progesterone Oral Suspension 40-mg/mL	Vol. 5 No. 4	297
Progesterone Enema 200-mg/mL	Vol. 5 No. 4	297
Xanthan Gum Oral Suspension Vehicle 0.3%	Vol. 5 No. 4	297
Wound Care Mixture	Vol. 5 No. 4	297
Cefazolin Ophthalmic Solution, USP 0.35- mg/mL	Vol. 5 No. 4	300
Cyclopentolate HCl 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution	Vol. 5 No. 4	301
Fibrin Glue	Vol. 5 No. 4	302
Hyaluronidase Injection	Vol. 5 No. 4	303
Hypertonic Sodium Chloride 20% Sclerotherapy Injections	Vol. 5 No. 4	304
Metronidazole and Neomycin Sulfate Irrigation Solution	Vol. 5 No. 4	305
Pediatric Preoperative Cocktail Injection	Vol. 5 No. 4	306
Phenylephrine 0.25% Ophthalmic Solution, Preservative Free	Vol. 5 No. 4	307
Sclerotherapy Injections of Phenol for Pain Management	Vol. 5 No. 4	308
Tissue Plasminogen Activator (TPA) 25-mcg/100-mcL Ophthalmic Solution	Vol. 5 No. 4	309
Wetting and/or Solubilizing Agents, Featured Excipient:	Vol. 5 No. 4	310
Maintenance of the Cleanroom	Vol. 5 No. 4	313
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration	Vol. 5 No. 4	314
A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes	Vol. 5 No. 4	320
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions	Vol. 5 No. 4	323
Calculations	Vol. 5 No. 4	325
PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor	Vol. 5 No. 4	328
Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want	Vol. 5 No. 5	332
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment	Vol. 5 No. 5	336
Bioidentical Hormones in the Treatment of Osteoporosis	Vol. 5 No. 5	339
The Value of Hormone Assessment	Vol. 5 No. 5	342
Estrogen Replacement: A Review of Current Literature	Vol. 5 No. 5	346
Treating Andropause: Prohormones and Hormone Metabolic Modifiers	Vol. 5 No. 5	351
Bioidentical Topical Progesterone: A Survey of Patients	Vol. 5 No. 5	354
Book Reviews: Hormone Replacement Therapy	Vol. 5 No. 5	356
Charting Systems: Organizing Information Effectively	Vol. 5 No. 5	360
Minimizing the Risk of Cholesterol-Lowering Therapy	Vol. 5 No. 5	362
Compounding in History: Treatment at the Change of Life	Vol. 5 No. 5	365
Flush Powder, No. 2	Vol. 5 No. 5	366
Tincture of Black Cohosh	Vol. 5 No. 5	366
Lydia Pinkham's Vegetable Compound	Vol. 5 No. 5	366
The Basics of Compounding: Tablets and Pills	Vol. 5 No. 5	369
Estriol 2-mg/mL and Estradiol 0.5-mg/mL in Pluronic Lecithin Organogel (PLO)	Vol. 5 No. 5	374
Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream	Vol. 5 No. 5	375
Libido Cream	Vol. 5 No. 5	376
Progesterone 50-mg/mL Clear Topical Solution	Vol. 5 No. 5	377
Progesterone Low-Potency 0.0065% Topical Cream	Vol. 5 No. 5	378
Sildenafil 1% Topical Cream	Vol. 5 No. 5	379
Testosterone 1-mg/0.1-mL Pluronic Lecithin Organogel (PLO)	Vol. 5 No. 5	380
Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches	Vol. 5 No. 5	381
Testosterone 25-mg/mL Clear Solution	Vol. 5 No. 5	382
Testosterone 2% Scalp Lotion	Vol. 5 No. 5	383
Compounding Containment Devices: Buyer Be Aware	Vol. 5 No. 5	384
Capsule and Tablet Disintegrating Agents, Featured Excipient:	Vol. 5 No. 5	389
Calculations	Vol. 5 No. 5	391
Developing a Capsule Formulation	Vol. 5 No. 5	392
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes	Vol. 5 No. 5	394
Assessment of the Stability of Teicoplanin in Intravenous Infusions	Vol. 5 No. 5	397
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release	Vol. 5 No. 5	401
PostScription: Compounding Errors: Lessons Learned, Never To Be Forgotten	Vol. 5 No. 5	408
High-tech Compounding: State-of-the-art Equipment Improves Products and Profit	Vol. 5 No. 6	412
High-tech Rx Compliance	Vol. 5 No. 6	419
High-tech Marketing Techniques	Vol. 5 No. 6	420
Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures	Vol. 5 No. 6	422
Nanotechnology: The Ultimate Alchemy	Vol. 5 No. 6	424
Future Trends in High-technology Pharmacy Compounding	Vol. 5 No. 6	426
Using Technology to Enhance the Practice of Pharmacy	Vol. 5 No. 6	427
Tips for Preventing Viruses…	Vol. 5 No. 6	430
Topical Secretin for the Treatment of Autism	Vol. 5 No. 6	436
Wish You Were Here: Vienna, Austria	Vol. 5 No. 6	438
Basics of Compounding: Parenteral Preparations	Vol. 5 No. 6	441
Acetic Acid 5% Iontophoresis Solution	Vol. 5 No. 6	450
Ceftazidime 20-mg/mL for Ambulatory Infusion Pump	Vol. 5 No. 6	451
Dexamethasone, Lidocaine, and Verapamil Iontophoresis Solutions for Peyronie's Disease	Vol. 5 No. 6	452
Doxycycline Hyclate 200-mg/mL Avian Injection	Vol. 5 No. 6	453
Hydrocortisone 10% Phonophoresis Gel	Vol. 5 No. 6	454
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution	Vol. 5 No. 6	455
Tissue Plasminogen Activator (TPA) 0.5-mg/mL, 1.0-mg/mL, or 2.0-mg/mL for Catheter Occlusion	Vol. 5 No. 6	456
Tobramycin-impregnated Polymethylmethacrylate Beads	Vol. 5 No. 6	457
Total Parenteral Nutrition Solution	Vol. 5 No. 6	458
Vancomycin 5-mg Sponge Disks	Vol. 5 No. 6	459
Hormone Replacement Therapy, Part 2: Estrogen Defined	Vol. 5 No. 6	460
The Science Behind Hormone Replacement Therapy, Part 1	Vol. 5 No. 6	462
New Perspectives on Vancomycin Use in Home Care, Part 1	Vol. 5 No. 6	465
Tablet and Lozenge Binders, Featured Excipient:	Vol. 5 No. 6	471
Training Personnel	Vol. 5 No. 6	474
Cross-contamination in Porcelain Mortars	Vol. 5 No. 6	476
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets	Vol. 5 No. 6	480
Stability of Pentobarbital Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Repackaging in Glass and Polypropylene Syringes	Vol. 5 No. 6	482
Calculations	Vol. 5 No. 6	485
PostScription: Lifelong Learning + Technology = Valuable Tools for the Compounding Pharmacist	Vol. 5 No. 6	488